Home › Compare › CYTHW vs BTI

CYTHW vs BTI: Dividend Comparison 2026

CYTHW yields 6250.00% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CYTHW wins by $547038161900822.13M in total portfolio value
10 years
CYTHW
CYTHW
● Live price
6250.00%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$547038161900822.19M
Annual income
$530,345,833,482,145,900,000.00
Full CYTHW calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — CYTHW vs BTI

📍 CYTHW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCYTHWBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CYTHW + BTI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CYTHW pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CYTHW
Annual income on $10K today (after 15% tax)
$531,250.00/yr
After 10yr DRIP, annual income (after tax)
$450,793,958,459,824,000,000.00/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, CYTHW beats the other by $450,793,958,459,824,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CYTHW + BTI for your $10,000?

CYTHW: 50%BTI: 50%
100% BTI50/50100% CYTHW
Portfolio after 10yr
$273519080950411.13M
Annual income
$265,172,916,741,072,950,000.00/yr
Blended yield
96.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

CYTHW
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
-46.3
Piotroski
2/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CYTHW buys
0
BTI buys
0
No recent congressional trades found for CYTHW or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCYTHWBTI
Forward yield6250.00% ✓5.38%
Annual dividend / share$2.00$3.15 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3% ✓
Portfolio after 10y$547038161900822.19M ✓$37.7K
Annual income after 10y$530,345,833,482,145,900,000.00 ✓$2,786.64
Total dividends collected$545916230838674.88M ✓$14.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: CYTHW vs BTI ($10,000, DRIP)

YearCYTHW PortfolioCYTHW Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$635,700$625,000.00$11,299$598.92+$624.4K → CYTHW
2$37,812,208$37,132,009.35$12,794$703.91+$37.80M → CYTHW
3$2,104,624,511$2,064,165,448.17$14,518$829.07+$2104.61M → CYTHW
4$109,626,980,731$107,375,032,504.06$16,513$978.64+$109626.96M → CYTHW
5$5,344,419,538,811$5,227,118,669,428.94$18,827$1,157.84+$5344419.52M → CYTHW
6$243,874,608,189,950$238,156,079,283,422.40$21,518$1,373.12+$243874608.17M → CYTHW
7$10,417,442,627,867,752$10,156,496,797,104,504.00$24,657$1,632.46+$10417442627.84M → CYTHW
8$416,612,895,336,954,560$405,466,231,725,136,060.00$28,329$1,945.74+$416612895336.93M → CYTHW
9$15,600,306,933,342,350,000$15,154,531,135,331,807,000.00$32,637$2,325.33+$15600306933342.32M → CYTHW
10$547,038,161,900,822,200,000$530,345,833,482,145,900,000.00$37,708$2,786.64+$547038161900822.13M → CYTHW

CYTHW vs BTI: Complete Analysis 2026

CYTHW — Stock

Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.

Full CYTHW Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this CYTHW vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CYTHW vs SCHDCYTHW vs JEPICYTHW vs OCYTHW vs KOCYTHW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.